NeuroPace, Inc. NPCE
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.22% | 3.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.22% | 3.43% | |||
| Cost of Revenue | -7.32% | -2.49% | |||
| Gross Profit | 2.99% | 4.75% | |||
| SG&A Expenses | -10.30% | 4.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.96% | 1.20% | |||
| Operating Income | 59.56% | 7.63% | |||
| Income Before Tax | 46.81% | 7.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 46.81% | 7.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 46.81% | 7.31% | |||
| EBIT | 59.56% | 7.63% | |||
| EBITDA | 60.61% | 7.82% | |||
| EPS Basic | 47.19% | 8.37% | |||
| Normalized Basic EPS | 50.35% | 8.39% | |||
| EPS Diluted | 47.19% | 8.37% | |||
| Normalized Diluted EPS | 50.35% | 8.39% | |||
| Average Basic Shares Outstanding | 0.71% | 1.15% | |||
| Average Diluted Shares Outstanding | 0.71% | 1.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||